We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

This study is currently recruiting participants.
Verified December 2017 by Bayer
Sponsor:
ClinicalTrials.gov Identifier:
NCT01947998
First Posted: September 23, 2013
Last Update Posted: December 13, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Janssen Research & Development, LLC
Information provided by (Responsible Party):
Bayer
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 31, 2019
  Estimated Primary Completion Date: December 31, 2018 (Final data collection date for primary outcome measure)